Physician
Psychiatry
Dr. Catherine M. Greene, MD
|
|
Give Review
Catherine Greene works in the field of Psychiatry. He graduated from University of Tennessee College of Medicine. Catherine M. Greene is also published. He has 92 publications published. The lastest publication: "Signal transduction pathways activated by the IL-1 receptor family: ancient signaling machinery in mammals, insects, and plants.'
Publications
- Differential in vitro and in vivo toxicities of antimicrobial peptide prodrugs for potential use in cystic fibrosis.
- The basophil surface marker CD203c identifies Aspergillus species sensitization in patients with cystic fibrosis.
- miRNA-221 is elevated in cystic fibrosis airway epithelial cells and regulates expression of ATF6.
- High-throughput profiling for discovery of non-coding RNA biomarkers of lung disease.
- miR-17 overexpression in cystic fibrosis airway epithelial cells decreases interleukin-8 production.
- Non-coding RNA as lung disease biomarkers.
- Therapeutic Aerosol Bioengineering of siRNA for the Treatment of Inflammatory Lung Disease by TNFα Gene Silencing in Macrophages.
- Protein quality control in lung disease: it's all about cloud networking.
- Bile acids stimulate chloride secretion through CFTR and calcium-activated Cl- channels in Calu-3 airway epithelial cells.
- Long noncoding RNA are aberrantly expressed in vivo in the cystic fibrosis bronchial epithelium.
- Clarification of the Risk of Chronic Obstructive Pulmonary Disease in α1-Antitrypsin Deficiency PiMZ Heterozygotes.
- miR-199a-5p Silencing Regulates the Unfolded Protein Response in COPD and α1 Antitrypsin Deficiency.
- MicroRNAs and liver cancer associated with iron overload: Therapeutic targets unravelled.
- Isolation and identification of cell-specific microRNAs targeting a messenger RNA using a biotinylated anti-sense oligonucleotide capture affinity technique.
- Regulation of Cystic Fibrosis Transmembrane Conductance Regulator by MicroRNA-145, -223, and -494 Is Altered in ?F508 Cystic Fibrosis Airway Epithelium.
- Is there a therapeutic role for selenium in alpha-1 antitrypsin deficiency?
- microRNAs in asthma: potential therapeutic targets.
- Pulmonary proteases in the cystic fibrosis lung induce interleukin 8 expression from bronchial epithelial cells via a heme/meprin/epidermal growth factor receptor/Toll...
- Measurement of the unfolded protein response (UPR) in monocytes.
- Protein misfolding and obstructive lung disease.
- 17Beta-estradiol inhibits IL-8 in cystic fibrosis by up-regulating secretory leucoprotease inhibitor.
- Evidence for unfolded protein response activation in monocytes from individuals with alpha-1 antitrypsin deficiency.
- miR-126 is downregulated in cystic fibrosis airway epithelial cells and regulates TOM1 expression.
- Inhibition of Toll-like receptor 2-mediated interleukin-8 production in Cystic Fibrosis airway epithelial cells via the alpha7-nicotinic acetylcholine receptor.
- Anti-proline-glycine-proline or antielastin autoantibodies are not evident in chronic inflammatory lung disease.
- LL-37 complexation with glycosaminoglycans in cystic fibrosis lungs inhibits antimicrobial activity, which can be restored by hypertonic saline.
- Selenoprotein S/SEPS1 modifies endoplasmic reticulum stress in Z variant alpha1-antitrypsin deficiency.
- Elafin, an elastase-specific inhibitor, is cleaved by its cognate enzyme neutrophil elastase in sputum from individuals with cystic fibrosis.
- Activation of the epidermal growth factor receptor (EGFR) by a novel metalloprotease pathway.
- Secretory leucocyte protease inhibitor inhibits interferon-gamma-induced cathepsin S expression.
- Tauroursodeoxycholic acid inhibits apoptosis induced by Z alpha-1 antitrypsin via inhibition of Bad.
- Neutrophil elastase up-regulates cathepsin B and matrix metalloprotease-2 expression.
- Elafin prevents lipopolysaccharide-induced AP-1 and NF-kappaB activation via an effect on the ubiquitin-proteasome pathway.
- Secretory leucoprotease inhibitor binds to NF-kappaB binding sites in monocytes and inhibits p65 binding.
- Viral inhibition of IL-1- and neutrophil elastase-induced inflammatory responses in bronchial epithelial cells.
- Endotoxin up-regulates interleukin-18: potential role for gram-negative colonization in sarcoidosis.
- Elastolytic proteases: inflammation resolution and dysregulation in chronic infective lung disease.
- TLR-induced inflammation in cystic fibrosis and non-cystic fibrosis airway epithelial cells.
- Loss of microbicidal activity and increased formation of biofilm due to decreased lactoferrin activity in patients with cystic fibrosis.
- Secretory leucoprotease inhibitor impairs Toll-like receptor 2- and 4-mediated responses in monocytic cells.
- Activation of endoplasmic reticulum-specific stress responses associated with the conformational disease Z alpha 1-antitrypsin deficiency.
- Z alpha1-antitrypsin polymerizes in the lung and acts as a neutrophil chemoattractant.
- Inactivation of human beta-defensins 2 and 3 by elastolytic cathepsins.
- Secretory leucoprotease inhibitor prevents lipopolysaccharide-induced IkappaBalpha degradation without affecting phosphorylation or ubiquitination.
- Tumor necrosis factor-alpha-converting enzyme: its role in community-acquired pneumonia.
- Anti-apoptotic effects of Z alpha1-antitrypsin in human bronchial epithelial cells.
- Vitamin D receptor agonists inhibit pro-inflammatory cytokine production from the respiratory epithelium in cystic fibrosis.
- Association of IL-10 polymorphism with severity of Illness in community acquired pneumonia.
- Biofilm and the role of the ica operon and aap in Staphylococcus epidermidis isolates causing neurosurgical meningitis.
- Interleukin-8 up-regulation by neutrophil elastase is mediated by MyD88/IRAK/TRAF-6 in human bronchial epithelium.
- Interleukin-1 receptor-associated kinase and TRAF-6 mediate the transcriptional regulation of interleukin-2 by interleukin-1 via NFkappaB but unlike interleukin-1 are ...
- Ambient pCO2 modulates intracellular pH, intracellular oxidant generation, and interleukin-8 secretion in human neutrophils.
- Alpha-1 antitrypsin deficiency: a conformational disease associated with lung and liver manifestations.
- A low-fibronectin-binding mutant of Staphylococcus aureus 879R4S has Tn918 inserted into its single fnb gene.
- Adhesion properties of mutants of Staphylococcus aureus defective in fibronectin-binding proteins and studies on the expression of fnb genes.
- Role of Staphylococcus aureus surface adhesins in orthopaedic device infections: are results model-dependent?
- Signal transduction pathways activated by the IL-1 receptor family: ancient signaling machinery in mammals, insects, and plants.
- Prevalence of Bartonella henselae antibodies in pet cats throughout regions of North America.
- Acylation of subtilisin Carlsberg by phenyl esters.
- miR-CATCH: MicroRNA Capture Affinity Technology.
- Aspergillus-associated airway disease, inflammation, and the innate immune response.
- Proteases and antiproteases in chronic neutrophilic lung disease - relevance to drug discovery.
- SLPI and inflammatory lung disease in females.
- Z α-1 antitrypsin deficiency and the endoplasmic reticulum stress response.
- Quantification and evaluation of the role of antielastin autoantibodies in the emphysematous lung.
- The role of proteases, endoplasmic reticulum stress and SERPINA1 heterozygosity in lung disease and α-1 anti-trypsin deficiency.
- Candida species in cystic fibrosis: A road less travelled.
- How can we target pulmonary inflammation in cystic fibrosis?
- MicroRNAs in inflammatory lung disease--master regulators or target practice?
- Alpha-1 antitrypsin deficiency.
- Targeting miRNA-based medicines to cystic fibrosis airway epithelial cells using nanotechnology.
- Functional study of elafin cleaved by Pseudomonas aeruginosa metalloproteinases.
- Gene targeted therapeutics for liver disease in alpha-1 antitrypsin deficiency.
- Biofilm characteristics of Staphylococcus epidermidis isolates associated with device-related meningitis.
- Toll-like receptors as therapeutic targets in cystic fibrosis.
- Staphylococcus epidermidis polysaccharide intercellular adhesin induces IL-8 expression in human astrocytes via a mechanism involving TLR2.
- Community-acquired pneumonia in older patients: does age influence systemic cytokine levels in community-acquired pneumonia?
- Effect of pro-inflammatory stimuli on mucin expression and inhibition by secretory leucoprotease inhibitor.
- Targeting neutrophil elastase in cystic fibrosis.
- Epithelial expression of TLR4 is modulated in COPD and by steroids, salmeterol and cigarette smoke.
- Antimicrobial proteins and polypeptides in pulmonary innate defence.
- Toll-like receptor expression and function in airway epithelial cells.
- Neutrophil elastase up-regulates interleukin-8 via toll-like receptor 4.
- Neutrophil elastase up-regulates human beta-defensin-2 expression in human bronchial epithelial cells.
- Role of IL-18 in CD4+ T lymphocyte activation in sarcoidosis.
- Respiratory epithelial cells require Toll-like receptor 4 for induction of human beta-defensin 2 by lipopolysaccharide.
- Local impairment of anti-neutrophil elastase capacity in community-acquired pneumonia.
- Alpha-1-antitrypsin aerosolised augmentation abrogates neutrophil elastase-induced expression of cathepsin B and matrix metalloprotease 2 in vivo and in vitro.
- High concentrations of pepsin in bronchoalveolar lavage fluid from children with cystic fibrosis are associated with high interleukin-8 concentrations.
- In vitro activities of synthetic host defense propeptides processed by neutrophil elastase against cystic fibrosis pathogens.
- Cathepsin B, L, and S cleave and inactivate secretory leucoprotease inhibitor.
Schools
University of Tennessee Memphis College of Medicine amp Surgery
Baptist Mem Hospital
Methodist Hsp Central Unit
University Of Tn College Of Med
Conditions Treated
- Bipolar Disorder
- Dysthymia and Cyclothymia (Mood Disorders)
- Psychosis Due to Mental Illness
- Schizophrenia
- View All
Doctors Specialties
- Psychiatry
Accepted Insurances
- Choice Plus POS II
- Blue Card PPO
- Blue Network E
- Network S
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- LocalPlus
- Open Access Plus
- Choice Care PPO
- Medicare MCR
- POMCO Group
- United Healthcare
- Worker's Compensation WC
Education
-
University of Tennessee -
University of Tennessee College of Medicine
Drug Facts
| NPI NUMBER | 1629176953 | |
| NPPES Provider LastName | GREENE | |
| NPPES Provider FirstName | CATHERINE | |
| NPPES Provider ZIPCode | 383052337 | |
| NPPES Provider State | TN | |
| Specialty Description | Psychiatry | |
| Total Claim Count | 2759.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1629176953 |
| Last Name Of The Provider | GREENE |
| First Name Of The Provider | CATHERINE |
| View All |
Similar Doctors
|
|
Dr. Debora C. Murphy, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sherwin A. Yaffe, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Janell J. Batchellor, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James W. Varner, MD |
|
|
Dr. Hilary F. Linder, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jeffrey M. Robbins, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kevin Turner, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Scott E. Baymiller, MD
This Doctor is OpenDoctor Recommended.
|